Appealit
Step 3 of 3 · Review & sign 6 citations verified

Free · patient submits · no account needed

Read your appeal, then sign it.

This is the letter you will send to UnitedHealthcare. Review it carefully, confirm the facts are right, and sign below. We don't file it for you — you submit it yourself. That's the point.

Green underline = verified citation (tap to view source)
Amber underline = needs your confirmation
6 citations verified Deadline: on your denial letter

Your appeal letter — SAMPLE (GLP-1 step-therapy)

Scroll to read all

June 21, 2026

UnitedHealthcare Appeals Department
P.O. Box 6106
Cyprus, CA 90630

RE: Appeal of Adverse Benefit Determination — Denial ID: DN-44821
Member: Maria L. Hernandez  |  Member ID: UHC-8847291
Medication: Wegovy (semaglutide 2.4 mg injection)  |  Denial Reason: Step Therapy Not Satisfied

Dear UnitedHealthcare Appeals Department,

I am writing to appeal your adverse benefit determination dated June 1, 2026, which denied coverage for Wegovy (semaglutide 2.4 mg) on the basis that I have not satisfied your step-therapy requirement. I respectfully request that you reverse this determination and approve coverage for Wegovy as prescribed by my physician, Dr. Anita Sharma, MD, at Austin Internal Medicine Associates.

Under , I am entitled to a full and fair review of this denial. I am submitting this appeal within the required 180-day timeframe and request a response within 60 days as required by that regulation. I have satisfied or am exempt from your step-therapy requirement for the reasons set out below, and the denial is inconsistent with your own published coverage policy.

1. Prior Treatment History Satisfies Step Therapy

I have an established diagnosis of obesity (BMI 41.2, ICD-10: E66.01) documented in medical records from Austin Internal Medicine Associates dated January 14, 2026. Prior to Dr. Sharma's recommendation of Wegovy, I completed a structured, supervised weight-management program and a 12-week course of orlistat (Alli 60 mg tid), which I documented in my pharmacy records. I lost fewer than 3% of body weight over 12 weeks despite full adherence, and orlistat was discontinued due to adverse gastrointestinal effects that interfered with my daily functioning. Under , one documented prior pharmacotherapy trial is the standard step requirement, and I have met it.

2. Medical Necessity is Established by FDA Labeling and Clinical Guidelines

Wegovy is . My BMI of 41.2 places me well within the approved indication. The . I have hypertension (ICD-10: I10) and pre-diabetes (ICD-10: R73.09), documented in attached records.

3. Step-Therapy Exception Applies Under State Law

Even if your plan policy required additional steps, . My documented adverse reaction to orlistat and clinical failure satisfy the contraindication and prior-adverse-reaction prongs of the statutory exception. Denial of the exception under these facts is inconsistent with Texas law.

4. Requested Relief

I request that UnitedHealthcare: (1) approve Wegovy (semaglutide 2.4 mg, weekly injection) for a 12-month supply as prescribed; (2) confirm that prior authorization will be valid for at least 12 months to allow for dose titration; and (3) respond in writing within 60 days as required by .

Attached to this appeal: (1) Denial letter dated June 1, 2026; (2) Letter of medical necessity from Dr. Anita Sharma, MD, dated June 10, 2026; (3) Pharmacy records documenting orlistat trial and discontinuation; (4) Medical records reflecting BMI, hypertension, and pre-diabetes diagnoses; (5) Insurance card (copy).

I am willing to provide additional documentation at your request. Please direct any questions or communications to me at: [email protected]  |  (512) 555-0193.

Respectfully submitted,

[Signed electronically below]
Maria L. Hernandez
Member ID: UHC-8847291
Date of Birth: March 7, 1981

Scroll to the end before signing
Appeal signed

Your appeal is ready to file. You submit it — here's what to do next.

Opens a print-ready packet — choose “Save as PDF.” Includes your cover sheet, the appeal letter, and your signature receipt.

Tamper-evident signature receipt

Keep this for your records. The hash proves the letter was not altered after you signed it.

Signer
Signed at
Consent versionv1
Scroll verifiedYes — document reviewed to end
SHA-256 hash

How to submit it yourself

  1. Download your packet above (cover sheet + signed letter + receipt).
  2. The exact fax number or appeal address is printed on your own denial letter — that is the authoritative destination for your specific plan. Send your appeal there by fax or mail.
  3. Keep your fax confirmation page if you fax, or use tracked/certified mail if you post it — that is your proof of delivery.

You are the appellant. AppealIt prepared this letter; you're sending it. Patient-submitted appeals carry full ERISA/ACA review rights.

Go to my appeal dashboard →

This letter is a draft prepared to help you exercise your right to appeal. AppealIt is not a law firm and does not provide legal or medical advice. Citations are verified against published sources; outcome is not guaranteed. You review and submit this appeal yourself. Consult a licensed attorney or patient advocacy organization if you have legal questions about your rights.